Institutional Ownership Zentalis Pharmaceuticals, Inc. (ZNTL)
This table provides information about the institutional ownership of Zentalis Pharmaceuticals, Inc. (ZNTL). We have compiled data on the 140 institutions that hold shares in the stock, with a total of 59.1 Million shares, which have been reported (via 13F filing form) to have a value of $74.4 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Gsa Capital Partners LLP
London, X0 |
May 08, 2025 Q1 2025 |
541,975
shares
|
$682,888
0.08% of portfolio
|
Q1 2025
Added 275.93%
|
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
530,582
shares
|
$668,533
0.01% of portfolio
|
Q4 2024
Reduced 49.72%
|
|
|
Nuveen, LLC
Charlotte, NC |
May 12, 2025 Q1 2025 |
507,527
shares
|
$639,484
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
5 Am Venture Management, LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
490,000
shares
|
$617,400
0.54% of portfolio
|
Q2 2023
New holding
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
486,499
shares
|
$612,988
0.0% of portfolio
|
Q1 2025
Reduced 2.18%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
462,303
shares
|
$582,501
0.0% of portfolio
|
Q1 2025
Reduced 4.63%
|
|
|
Goldman Sachs Group Inc
New York, NY |
May 16, 2025 Q1 2025 |
456,393
shares
|
$575,055
0.0% of portfolio
|
Q1 2025
Reduced 50.29%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
447,400
shares
|
$563,724
0.0% of portfolio
|
Q1 2025
Reduced 11.41%
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
May 12, 2025 Q1 2025 |
361,236
shares
|
$455,157
0.0% of portfolio
|
Q1 2025
Added 4.69%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
May 15, 2025 Q1 2025 |
348,965
shares
|
$439,695
0.0% of portfolio
|
Q1 2025
Added 50.38%
|
|
|
Walleye Capital LLC
Plymouth, MN |
May 14, 2025 Q1 2025 |
341,388
shares
|
$430,148
0.0% of portfolio
|
Q1 2025
Added 76.24%
|
|
|
Creative Planning
Overland Park, KS |
May 15, 2025 Q1 2025 |
236,523
shares
|
$298,018
0.0% of portfolio
|
Q1 2025
Added 489.79%
|
|
|
Wealth Enhancement Advisory Services, LLC
|
Apr 16, 2025 Q1 2025 |
234,071
shares
|
$294,929
0.0% of portfolio
|
Q1 2025
Added 16.97%
|
|
|
Sei Investments CO
Oaks, PA |
May 14, 2025 Q1 2025 |
202,420
shares
|
$255,049
0.0% of portfolio
|
Q1 2025
Added 473.1%
|
|
|
Mayo Clinic
Rochester, MN |
Nov 12, 2024 Q3 2024 |
175,000
shares
|
$220,500
23.63% of portfolio
|
Q3 2024
Reduced 6.49%
|
|
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
159,836
shares
|
$201,393
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
May 15, 2025 Q1 2025 |
152,300
shares
|
$191,898
0.01% of portfolio
|
Q1 2025
Reduced 12.97%
|
|
|
Russell Investments Group, Ltd.
|
May 13, 2025 Q1 2025 |
152,255
shares
|
$191,841
0.0% of portfolio
|
Q1 2025
Added 153.67%
|
|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
149,484
shares
|
$188,349
0.0% of portfolio
|
Q1 2025
Added 193.84%
|
|
|
Jane Street Group, LLC
New York, NY |
May 19, 2025 Q1 2025 |
148,804
shares
|
$187,493
0.0% of portfolio
|
Q1 2025
Reduced 54.0%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
141,936
shares
|
$178,839
0.0% of portfolio
|
Q1 2025
Reduced 22.73%
|
|
|
Graham Capital Management, L.P.
Rowayton, CT |
May 15, 2025 Q1 2025 |
124,801
shares
|
$157,249
0.0% of portfolio
|
Q1 2025
Added 115.37%
|
|
|
Xtx Topco LTD
London, X0 |
May 07, 2025 Q1 2025 |
124,396
shares
|
$156,738
0.01% of portfolio
|
Q1 2025
Added 1.14%
|
|
|
Algert Global LLC
San Francisco, CA |
May 13, 2025 Q1 2025 |
122,348
shares
|
$154,158
0.0% of portfolio
|
Q1 2025
Added 139.43%
|
|
|
Verition Fund Management LLC
Greenwich, CT |
May 15, 2025 Q1 2025 |
122,282
shares
|
$154,075
0.0% of portfolio
|
Q1 2025
Reduced 89.95%
|